FSPHX
Price
$25.68
Change
-$0.03 (-0.12%)
Updated
Apr 11 closing price
Net Assets
6.42B
GGHSX
Price
$37.08
Change
+$0.61 (+1.67%)
Updated
Apr 11 closing price
Net Assets
1.15B
Ad is loading...

FSPHX vs GGHSX

Header iconFSPHX vs GGHSX Comparison
Open Charts FSPHX vs GGHSXBanner chart's image
Fidelity Select Health Care
Price$25.68
Change-$0.03 (-0.12%)
VolumeN/A
Net Assets6.42B
Invesco Health Care R6
Price$37.08
Change+$0.61 (+1.67%)
VolumeN/A
Net Assets1.15B
FSPHX vs GGHSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSPHX vs. GGHSX commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSPHX is a Hold and GGHSX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 6.42B vs. GGHSX (1.15B). FSPHX pays higher dividends than GGHSX: FSPHX (0.02) vs GGHSX (0.00). FSPHX was incepted earlier than GGHSX: FSPHX (44 years) vs GGHSX (8 years). GGHSX (0.71) is less costly to investors than FSPHX (0.65). GGHSX is a more actively managed with annual turnover of: 56.00 vs. FSPHX (46.00). FSPHX has a lower initial minimum investment than GGHSX: FSPHX (0) vs GGHSX (1000000). GGHSX annual gain was more profitable for investors over the last year : -9.21 vs. FSPHX (-13.51). FSPHX return over 5 years is better than : -0.27 vs. GGHSX (-4.42).
FSPHXGGHSXFSPHX / GGHSX
Total Expense Ratio0.650.7192%
Annual Report Gross Expense Ratio0.650.7192%
Fund Existence44 years8 years-
Gain YTD-5.651-2.251251%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets6.42B1.15B557%
Annual Yield % from dividends0.020.00-
Returns for 1 year-13.51-9.21147%
Returns for 3 years-10.53-5.00210%
Returns for 5 years-0.27-4.426%
Returns for 10 years7.67N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JPVZX14.23N/A
N/A
JPMorgan Developed International ValueR2
NINDX53.19N/A
N/A
Columbia Large Cap Index Inst
RMDAX3.97N/A
N/A
Virtus Silvant Mid-Cap Growth A
LBSAX31.44N/A
N/A
Columbia Dividend Income A
NSMAX27.42N/A
N/A
Nuveen Small/Mid-Cap Value A